Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Total World Stock Index Fund ETF (VT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Vanguard Total World Stock Index Fund ETFTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Vanguard Total World Stock Index Fund ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Vanguard Total World Stock Index Fund ETF trades at $161.54, while State Street SPDR S&P Biotech ETF trades at $158.1. Which is the better fit depends on your goals.

VTXBI
Sector
Broad Market / FactorBroad Market / Factor
52-Week High
$161.30$164.28
52-Week Low
$132.19$86.92

Returns comparison

Trailing returns across standard periods

About Vanguard Total World Stock Index Fund ETF

VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.

Read more on VT

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI